Entyvio Continues to Show Benefits for Inflammatory Bowel Disease

Thanks to regulatory organizations such as the FDA and the European commission, thorough clinical trials are conducted prior to drugs going on the market. After public release, the safety, efficacy, and tolerability of medications is evaluated through real-world data collection. As we move forward with medication development, hopefully providers will continue to use a combination of pharmaceuticals and lifestyle changes to help patients manage their IBD.